Are you Dr. Nierenberg?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 60 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1 Medical Center Dr
DHMC Dept of Clinical Pharmacology
Lebanon, NH 03756Phone+1 603-650-7679Fax+1 603-650-6841
Summary
- Dr. David Nierenberg, MD is a board certified internist in Lebanon, New Hampshire. He is currently licensed to practice medicine in New Hampshire and Vermont. He is affiliated with Dartmouth-Hitchcock Medical Center and is a Professor at Geisel School of Medicine.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1980 - 1981
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1976 - 1978
- Harvard Medical SchoolClass of 1976
Certifications & Licensure
- VT State Medical License 1993 - 2026
- NH State Medical License 1981 - 2025
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- The clinical pharmacology and therapeutics course for graduating medical students at Dartmouth: Preparation for internship and residency.David W Nierenberg, Lionel D Lewis
British Journal of Clinical Pharmacology. 2024-07-30 - 1 citationsA New Initiative With Multiple Sponsors to Help Prepare Medical Students to Be Safe and Effective PrescribersDavid W. Nierenberg, E Cannon
Clinical Pharmacology and Therapeutics. 2015-03-01 - 7 citationsEducational epidemiology [1] (multiple letters)Thomas J. Beckman, David A. Cook, Afschin Gandjour, Susan L. Rattner, J. Jon Veloski
JAMA. 2004-12-22
Grant Support
- Core--Clinical PharmacologyNational Cancer Institute1997–2002
- Human Blood/Tissue Levels/Vitamins A, E, &CarotenoidsNational Cancer Institute1990–1993
- Seasonal And Diurnal Variation In Serum CarotenoidsNational Cancer Institute1987–1988
- Adverse Methotrexate-Drug InteractionsNational Cancer Institute1985–1986